University of Wollongong
Browse

Is Seladin-1 really a selective Alzheimer's disease indicator?

Download (435.75 kB)
journal contribution
posted on 2024-11-16, 07:41 authored by Laura J Sharpe, Jenny Wong, Brett Garner, Glenda M Halliday, Andrew J Brown
Selective Alzheimer's Disease Indicator-1 (Seladin-1) was originally identified by its down-regulation in the brains of Alzheimer's disease (AD) patients. Here, we re-examine existing data and present new gene expression data that refutes its role as a selective AD indicator. Furthermore, we caution against the use of the name “Seladin-1” and instead recommend adoption of the approved nomenclature, 3β-hydroxysterol Δ24-reductase (or DHCR24), which describes its catalytic function in cholesterol synthesis. Further work is required to determine what link, if any, exists between DHCR24 and AD.

Funding

EVIDENCE OF (SELF)TRAINING OF WORKERS IN THE PRESS: AFFECTING THE SENSES, PRODUCING SENSITIVITIES (between the final decades of the 19th century and the beginning of the 21st century)

Coordenação de Aperfeicoamento de Pessoal de Nível Superior

Find out more...

History

Citation

Sharpe, L. J., Wong, J., Garner, B., Halliday, G. M. & Brown, A. J. (2012). Is Seladin-1 really a selective Alzheimer's disease indicator?. Journal of Alzheimer's Disease, 30 (1), 35-39.

Journal title

Journal of Alzheimer's Disease

Volume

30

Issue

1

Pagination

35-39

Language

English

RIS ID

58084

Usage metrics

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC